制度・支援
指定難病 — No.165

肥厚性皮膚骨膜症

検索語 Pachydermoperiostosis ・ 最終更新 2026-09-17 14:12 ・ 最新に更新

Data Sheet
指定 No.165
Src PubMed · CT.gov · jRCT

これは医療アドバイスではありません。診断・治療の判断は必ず主治医にご相談ください。論文や治験は「今わかっている研究の状況」を示すもので、効果を保証するものではありません。

( 01 )EVIDENCE / PUBMED · 5件

世界の論文

直近の研究を、やさしい日本語で

各論文の見出しにある「確からしさ」は、その研究がどれくらい信頼できるかの目安です。「理論段階」はまだ仮説に近く、下にいくほど多くの患者で検証されていて、「メタ解析」がもっとも信頼できます。

不明
MK-01 · PMID 42570932

Pachydermoperiostosis beyond juvenile idiopathic arthritis

Journal
Anales de pediatria(2026 Aug)
Authors
4名
Type
Journal Article
PubMedで原文を見る
観察研究
MK-02 · PMID 42558538

Cutis Verticis Gyrata Across the Diagnostic Spectrum: Two Cases Highlighting Challenges in Clinical Classification

Abstract / 原文

Cutis verticis gyrata (CVG) is an uncommon disorder characterized by cerebriform thickening of the scalp that may occur as a primary condition or secondary to a variety of systemic disorders. We report two patients with clinically distinct presentations of CVG illustrating the diagnostic challenges encountered during classification. A 40-year-old man presented with progressive scalp thickening and visual impairment, raising suspicion for primary non-essential or secondary CVG; however, definitive classification was not possible because further ophthalmological and systemic investigations could not be completed after he was lost to follow-up. A 28-year-old man presented with asymptomatic scalp folds accompanied by seborrhea and comedonal acne, initially suggesting pachydermoperiostosis. However, normal laboratory and endocrine investigations, including normal serum growth hormone levels, together with the absence of digital clubbing, periostosis, and radiographic abnormalities, favored primary essential CVG. These cases emphasize that CVG should be regarded as a clinical sign requiring systematic neurological, ophthalmological, endocrine, skeletal, and dermatological evaluation before definitive classification.

Journal
Clinical case reports(2026 Aug)
Authors
3名
Type
Journal Article
PubMedで原文を見る
症例報告
MK-03 · PMID 42557004

Rheumatological mimic: primary hypertrophic osteoarthropathy initially treated as juvenile idiopathic arthritis

Abstract / 原文

Primary hypertrophic osteoarthropathy (PHO) is a rare genetic disorder that closely mimics inflammatory arthritis, leading to diagnostic delays and inappropriate treatment. We report the case of an adolescent boy who presented with a 2-year history of intermittent joint pain and swelling and was initially diagnosed with juvenile idiopathic arthritis at a primary care centre. He was treated with sulfasalazine but experienced only partial symptomatic relief. Laboratory evaluation at the referring centre showed a negative rheumatoid factor and mildly elevated C-reactive protein. Persistent symptoms prompted re-evaluation, which revealed clinical features and a positive family history consistent with PHO. Recognition of characteristic clinical findings and family history led to the correct diagnosis, allowing discontinuation of the disease-modifying anti-rheumatic therapy. This case highlights the importance of considering PHO in the differential diagnosis of chronic arthritis in children, particularly in those with a positive family history.

Journal
BMJ case reports(2026 Aug)
Authors
3名
Type
Journal Article, Case Reports
PubMedで原文を見る
症例報告
MK-04 · PMID 42555497

Primary hypertrophic osteoarthropathy with anemia as assessed by 18F-FDG PET/CT

Abstract / 原文

Primary hypertrophic osteoarthropathy (PHO), also known as pachydermoperiostosis, is a rare genetic disorder with autosomal inheritance. We present the case of a 31-year-old male with a disease onset at 12 years of age, initially presenting as digital clubbing of the hands and feet and ankle joint hypertrophy. The clinical phenotype progressed significantly by age 17, with the development of marked facial skin thickening, deepened centripetal skin folds, a corrugated scalp, hypertrophic alae nasi, acne, ptosis, and palmoplantar hyperhidrosis. Anemia was identified at age 19, accompanied by persistent fatigue, followed by the onset of bilateral knee joint pain two years later. Fluorine-18-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) imaging revealed a constellation of findings that can be grouped into three categories: (1) skeletal: cortical thickening and periosteal reaction in the long bones of the lower limbs, along with extensively increased bone marrow density throughout the skeleton; (2) soft tissue: diffuse thickening of the cranial and facial skin, and multiple para-spinal soft tissue foci; and (3) systemic: cardiac findings suggestive of anemia-related adaptation. Genetic analysis confirmed the diagnosis by identifying heterozygous mutations in the SLCO2A1 gene (c.290G>A [p.R97H] and c.1295+1G>A), establishing PHO complicated by anemia.

Journal
Hellenic journal of nuclear medicine(2026)
Authors
3名
Type
Journal Article, Case Reports
PubMedで原文を見る
症例報告
MK-05 · PMID 42550166

Complete Pachydermoperiostosis With Acromegaloid Phenotype: Characteristic 99m Tc-Methylene Diphosphonate (MDP) Skeletal Scintigraphy in a Rare Clinical Mimic of Acromegaly

Abstract / 原文

Pachydermoperiostosis (Touraine-Solente-Gole syndrome) is a rare disorder that can mimic acromegaly and should be considered a differential in patients with acromegaloid features. A 21-year-old man with acral enlargement, coarse facial features, joint pain, and hyperhidrosis, initially evaluated for acromegaly but eventually diagnosed as familial complete pachydermoperiostosis. 99m Tc-methylene diphosphonate skeletal scintigraphy showed increased perfusion, soft tissue and pericortical linear tracer uptake in the distal one third of tibiae, fibulae, and around the knee joint with periosteal thickening. The typical linear pattern of symmetrical tracer uptake at the end of long bones differentiates pachydermoperiostosis from secondary hypertrophic osteoarthropathy, which often shows asymmetric involvement.

Journal
Clinical nuclear medicine(2026 Oct)
Authors
5名
Type
Journal Article, Case Reports
PubMedで原文を見る
( 02 )TRIALS / JAPAN · 0件

日本で参加できる治験

現在 募集中のもの

日本で現在募集中の治験は見つかりませんでした。下の公式レジストリで条件を変えると見つかる場合があります。
( 03 )REGISTRY / jRCT

治験をもっと探す

日本の公式レジストリで全件を確認

上の一覧は ClinicalTrials.gov の一部です。日本国内の治験の多くは、日本の公式レジストリ jRCT にのみ登録されています。下記から最新の全件を確認できます。

jRCT で検索日本の臨床研究実施計画 公開システム「対象疾患名」に 肥厚性皮膚骨膜症 を入力し、「募集状況」で 募集中 にチェックして検索します。ClinicalTrials.gov で全件を見る世界最大の治験データベース(英語)「肥厚性皮膚骨膜症・日本・募集中」の条件で一覧が開きます。

※ jRCTは自動の大量データ取得を禁じているため、本サービスは自動収集せず、ご自身が公式サイトで検索できるリンクでご案内しています(規約順守)。

お金・介護・制度肥厚性皮膚骨膜症の療養に使えるかもしれない公的サポートを調べる医療費・生活費・介護の支援制度と相談先を、あなたの状況に合わせてご案内(回答は端末内で完結)
( 04 )SUPPORT

患者会・相談窓口

一人で抱え込まないでください

同じ病気の患者・家族とつながる、制度や生活の相談をする、といったときの窓口です。

全国の相談先

※ お住まいの都道府県の「難病相談支援センター」でも、医療費助成や療養生活の相談ができます(難病情報センターから探せます)。